跳至主要内容
临床试验/NCT06458764
NCT06458764招募中不适用

SEXCHECK - Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study

Candiolo Cancer Institute - IRCCS1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150
试验地点
1
主要终点
Sexual Dysfunction (SD) incidence

研究概览

简要总结

Primary objectives:

  • To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy.
  • To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life.

Secondary objectives:

  • To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens.
  • Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women aged ≥18 and ≤ 55
  • who underwent surgery for early stage breast cancer
  • taking endocrine therapy for at least 3 months
  • providing an informed consent and completing the study questionnaires.

排除标准

  • withdrawal of the informed consent, at any time

结局指标

主要结局

Sexual Dysfunction (SD) incidence

时间窗: 6 months

To estimate Sexual Dysfunction (SD) incidence (physiological parameter) in premenopausal breast cancer patients treated by surgery and taking endocrine therapy.

SD-related distress

时间窗: 6 months

To detect the presence of SD-related distress (physiological parameter) in the population, as a determining factor in the maintenance of a good quality of life.

次要结局

  • SD characteristics(6 months)
  • Collect baseline data(6 months)

研究者

发起方
Candiolo Cancer Institute - IRCCS
申办方类型
Other
责任方
Principal Investigator
主要研究者

Giada Pozzi

MD

Candiolo Cancer Institute - IRCCS

研究点 (1)

Loading locations...

相似试验